
Following controversy, new Biogen director Susan Langer won fewest votes from shareholders
After her controversial nomination by Alex Denner to Biogen’s board, Susan Langer was elected this week with fewer votes than any other member of the eight-person group. According to an SEC filing, 64 million shares […]